Workflow
Repeat Precision
icon
Search documents
Stonegate Updates Coverage on NCS Multistage Holdings, Inc. (NCSM) 2025 Q4
TMX Newsfile· 2026-03-06 14:21
Core Insights - NCS Multistage Holdings, Inc. (NASDAQ: NCSM) reported a revenue growth of 13% to $183.6 million in FY25, driven by product strength and market momentum despite challenging conditions [1][5] - The company achieved a 20% increase in adjusted EBITDA to $26.7 million, with an EBITDA margin expansion of approximately 80 basis points to 15% [1] - Free cash flow after non-controlling interests nearly doubled to $18.9 million, highlighting the benefits of the company's asset-light model [1] Revenue Growth - Revenue for FY25 reached $183.6 million, reflecting a 13% increase year-over-year [1] - Excluding the contribution from ResMetrics, revenue still increased by 10% [1] Profitability Metrics - Adjusted EBITDA rose by 20% to $26.7 million [1] - EBITDA margin expanded by around 80 basis points to 15% [1] - Adjusted gross margin remained stable at 41% despite service-mix pressures [1] Cash Flow and Financial Health - Free cash flow after non-controlling interests nearly doubled to $18.9 million [1] - The company exited FY25 with a strong balance sheet, enabling continued reinvestment and M&A flexibility [5] Market Performance - The fourth quarter of FY25 significantly exceeded expectations, driven by accelerated U.S. fracturing demand and constructive international markets [5] - The outperformance in FY25 was attributed to share gains, product execution, and the incremental contribution from ResMetrics following its acquisition [5]
NCS Multistage Holdings, Inc. Announces Fourth Quarter and Full Year 2025 Results
Globenewswire· 2026-03-04 21:05
Core Insights - NCS Multistage Holdings, Inc. reported a 13% increase in total revenue for the year 2025, reaching $183.6 million, driven by strong performance in the U.S. and contributions from the acquisition of ResMetrics [5][18] - The company achieved an Adjusted EBITDA of $26.7 million for 2025, reflecting a 20% improvement from 2024, with an Adjusted EBITDA margin of 15% [6][23] - Free cash flow after distributions to non-controlling interest reached $18.9 million, a significant increase of $9.0 million year-over-year, indicating strong cash generation capabilities [6][24] Fourth Quarter Results - Total revenues for Q4 2025 were $50.6 million, a 13% increase compared to Q4 2024, with U.S. revenues rising by 69% [7][10] - Operating income for Q4 2025 was $5.2 million, a 78% increase year-over-year, while net income reached $15.0 million, or $5.34 per diluted share [7][17] - Adjusted EBITDA for Q4 2025 was $9.2 million, up from $8.2 million in Q4 2024, maintaining an Adjusted EBITDA margin of 18% [7][17] Financial Performance - Gross profit for the year was $72.4 million, with a gross margin of 39%, slightly down from 40% in 2024 [19] - SG&A expenses totaled $58.8 million for 2025, reflecting a slight increase from $57.8 million in 2024, with contributions from ResMetrics included [20] - The company reported a net income of $23.7 million for 2025, compared to $6.6 million in 2024, highlighting significant profitability improvements [22] Liquidity and Capital Expenditures - As of December 31, 2025, NCS had $36.7 million in cash and $7.6 million in total debt, providing substantial financial flexibility [26] - Working capital increased to $93.4 million from $80.2 million in 2024, indicating improved operational efficiency [27] - Capital expenditures for 2025 were $0.5 million, down from $0.8 million in 2024, reflecting a disciplined approach to investment [28] Market Outlook - The company anticipates continued challenges in 2026 due to commodity price levels and customer budget discipline, particularly in the U.S. and Canada [9] - NCS expects to gain market share and expand internationally, particularly in the Middle East, despite facing headwinds from customer consolidation [9][10]
NCS Multistage (NasdaqCM:NCSM) Conference Transcript
2025-12-10 19:47
NCS Multistage Conference Call Summary Company Overview - **Company**: NCS Multistage (Ticker: NCSM) - **Industry**: Oil field services and equipment - **Market Capitalization**: Approximately $115 million - **Trailing 12-month EBITDA**: Approximately $26 million - **Free Cash Flow**: Approximately $20 million - **Revenue for 2025**: Expected to be close to $180 million, representing about 2% market share in a nearly $10 billion addressable market for oil field services in 2025 [5][18] Core Business and Product Lines - **Focus**: Technology-driven solutions for oil and natural gas producers, including major companies like Chevron, BP, and Saudi Aramco [2][3] - **Product Lines**: 1. **Fracturing Systems**: Accounts for about 60% of revenue; helps maximize resource recovery [5][6] 2. **Repeat Precision**: Second largest product line, known for high-performance composite frac plugs [8][9] 3. **Tracer Diagnostics**: Provides cost-effective services to improve well designs and optimize field development [10][11] 4. **Well Construction**: Features the AirLock casing buoyancy system, aiding in drilling longer laterals [12][13] Strategic Focus and Growth Opportunities - **Market Positioning**: Aims to build on leadership in fracturing systems and capitalize on high-margin growth opportunities, particularly in international markets [15][19] - **International Revenue Growth**: More than doubled in 2024 compared to 2023, increasing from about 5% to 10% of total revenue [17] - **Acquisition of ResMetrics**: Enhances Tracer Diagnostics capabilities, with trailing 12-month revenues of over $10 million and an EBITDA margin of over 30% [20][22] Financial Performance and Projections - **Revenue Growth**: Grew by 14% or $20 million in 2024; projected 8% growth in 2025, with 5% from organic initiatives and 3% from ResMetrics acquisition [27] - **Gross Margin**: Approximately 40%, improved by about 250 basis points in 2024 compared to 2023 [28] - **Free Cash Flow Generation**: Expected to convert about 50%-60% of Adjusted EBITDA to free cash flow [30] Market Dynamics and Competitive Landscape - **Challenging Market Environment**: Despite a flat-to-lower completion count and reduced rig count in the U.S., NCS is gaining market share through differentiated products [35][36] - **International Expansion**: Significant growth opportunities identified in unconventional markets like Argentina (Vaca Muerta) and the Middle East [42][44] Investor Considerations - **Valuation**: Currently trading at about four times enterprise value to 2025 EBITDA, which is a discount compared to peers [31] - **Shareholder Support**: Advent International holds over 50% of shares and has been supportive of management and strategic initiatives [46][48] Conclusion - **Investment Opportunity**: NCS Multistage presents a compelling investment case with strong organic growth, innovative technology, and a capital-light business model that generates free cash flow through industry cycles [32][33]
NCS Multistage (NCSM) Conference Transcript
2025-08-21 15:00
Summary of NCS Multistage Holdings Conference Call Company Overview - NCS Multistage Holdings is a technology-focused oilfield services and equipment company, selling directly to oil and natural gas producers such as Chevron, Conoco, and BP [4][5] - Competes with larger companies like Schlumberger and Halliburton, focusing on areas where it can achieve leadership and attractive margins [5] - Operates a capital-light business model, outsourcing manufacturing to minimize capital investment and generate free cash flow [6] Financial Highlights - Recent market capitalization and enterprise value are just below $90 million, with trailing twelve-month EBITDA of $26 million and free cash flow of $10 million [7] - Revenue grew by 14% or $20 million in 2024, with expectations for continued growth in 2025 despite a challenging market [23] - Gross margin approximately 40%, with an improvement of 200 basis points in 2024 compared to 2023 [24] - Free cash flow generation expected to be between $7 million and $11 million for the year [49] Product Lines - **Fracturing Systems**: Represents about 60% of revenue, helping customers maximize resource recovery [8][10] - **Repeat Precision**: Second-largest product line, expanding its offerings to capture additional market share [11][12] - **Tracer Diagnostics**: Acquired in 2017, provides cost-effective services to improve well designs and field development strategies [13][14] - **Well Construction**: Focuses on technologies that assist in drilling longer laterals, enhancing economic returns [15][16] Strategic Initiatives - Three core business strategies introduced in late 2022: 1. Build on leading market positions in fracturing systems and tracer diagnostics [17] 2. Capitalize on offshore and international opportunities, with international revenue doubling from 5% to 10% of total revenue [20] 3. Commercialize innovative solutions to complex customer challenges [19][21] - Recent acquisition of ResMetrix enhances tracer diagnostics capabilities and expands market presence in the Middle East [28][30] Market Dynamics - North American market for unconventional development is maturing, with customers focusing on value over volume [40] - International markets, particularly in the North Sea and Middle East, are seen as growth opportunities [41][42] - Tracer diagnostics is a discretionary service, but its use is expected to grow as operators seek to optimize production profiles [44][46] Cash Management and Future Outlook - The company maintains a strong balance sheet with approximately $25 million in cash and $17 million available through a revolving credit facility [35] - Limited capital expenditure (CapEx) of about 1-2% of revenue, allowing for operational leverage and free cash flow generation [52][54] - The management is open to strategic acquisitions but also considers stock buybacks if suitable opportunities do not arise [56][59] Conclusion - NCS Multistage Holdings presents a compelling investment opportunity with a strong growth track record, innovative technology, and a capital-light business model that supports free cash flow generation [33][34]